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Patients with non-valvular atrial fibrillation (AF) requiring 
oral anticoagulants (OAC) for stroke prevention 
currently have a choice of five OACs. A systematic 
review was undertaken to explore if patients with AF 
requiring an OAC for stroke prevention are involved in 
decision-making. 
A systematic search was conducted using MEDLINE, 
EMBASE, Web of Science, CINAHL, Cochrane 
Library, SCOPUS, and PsycINFO databases from 
inception to August 2017. Search terms were developed 
from search categories: “atrial fibrillation” AND “oral 
anticoagulant” AND “patient involvement”. English 
language filter was applied. Studies retrieved, after 
removal of duplicates, were screened using the following 
inclusion criteria: (i) empiric studies reporting patient 
involvement in decision-making about OACs for stroke 
prevention in AF (ii) >18 years participants. Clinical 
guidelines, reviews, opinion and incomplete articles were 
excluded. The first reviewer screened titles and abstracts. 
To ensure concordance, a second reviewer independently 
checked a subset of 20% of abstracts. Once screened, 
reference checking and citation searches were performed. 
The full text of selected articles was assessed for inclusion 
by two reviewers independently and discussed to 
reach consensus. One reviewer conducted data extraction, 
quality appraisal using QATSDD evaluation tool 
[1] and analysis of eligible studies. Ethical approval was 
not required. 
The search yielded 5,894 unique titles. Screening of 
titles and abstracts resulted into 27 papers. The full text 
review excluded 19 papers. Reasons for exclusion were: 
review papers (n = 9), no findings on patient involvement 
in decision-making (n = 7), and clinical guidelines 
(n = 3). Two additional studies were included after reference 
and citations screening. Ten papers, seven qualitative 
and three quantitative studies, were retained for the 
literature review. Four studies were conducted in the 
UK, two in Canada and the remaining in Australia, 
USA, Denmark, and one across Europe. The methodological 
quality of studies was varied (score 13–29 out 
of 42, median 24.5). Four studies explored patient 
involvement when warfarin was the only OAC option 
and six when warfarin and direct oral anticoagulants 
(DOACs) were available. Views on patient involvement 
in decision-making from a patient’s perspective were 
reported in six studies and from a prescriber’s perspective 
in six studies. 
Patients’ experiences indicated that paternalistic consultations 
were dominant when warfarin was the only 
available OAC. Patients reported high trust in doctors 
and expressed low confidence in making decisions 
themselves. They accepted physicians’ dominance in the 
consultations even if an active role was preferred. Physicians’ 
aimed to involve patients in decisions through 
negotiation. However, in order to make the “right” decision 
they fell back to the paternalistic approach or limited 
patient involvement. Patients continued to 
experience paternalistic consultations when warfarin and 
DOACs were available. Furthermore, quantitative findings 
have suggested that when more OAC options 
were available patients tended to be more involved in 
decisions. 
This systematic review suggests that decision-making 
is dominated by prescribers but providing patients with 
several therapy options can promote their involvement 
in decisions. Further planned work will explore if 
patient involvement in decision-making has influenced 
the uptake of DOACs, which has been slow in the 
UK.[2] 
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